National Biomedical Information Services
国家生物医学信息服务
基本信息
- 批准号:10927115
- 负责人:
- 金额:$ 35884.77万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:
- 资助国家:美国
- 起止时间:至
- 项目状态:未结题
- 来源:
- 关键词:2019-nCoVAccelerationAdoptionAfrican AmericanAlaska NativeAmerican IndiansAntimicrobial ResistanceArtificial IntelligenceAsian AmericansAuthorization documentationAutomated IndexingAwarenessBioinformaticsBiologicalBiomedical EngineeringBiomedical ResearchBiotechnologyBlack AmericanBooksCOVID-19COVID-19 pandemicChemicalsClinVarClinicalClinical DataClinical ResearchClinical TrialsCodeCollaborationsCollectionCommon Data ElementCommunitiesComparative Genomic AnalysisComputational ScienceCoronavirusDNA SequenceDataData AnalysesData ScienceData SetData Storage and RetrievalDatabasesDevelopmentDisciplineDiverse WorkforceDrug LabelingEarly InterventionEcosystemElectronic Health RecordEmergency responseEnsureEpidemiologyEscherichia coliEthnic OriginFamilyFederal GovernmentFeedbackFrequenciesFundingGenbankGeneticGenomeGenomicsGoalsHealthHealth ProfessionalHealth ServicesHealth Services ResearchHealth TechnologyHealthcareHispanicHistory of MedicineHumanHuman GeneticsHuman GenomeIndividualInformation DisseminationInformation ServicesInformation SystemsInfrastructureInterlibrary LoansInternationalIntramural Research ProgramJournalsKnowledgeLatinoLeadershipLibrariesLinguisticsListeriaLiteratureLocal GovernmentLogical Observation Identifiers Names and CodesMEDLINEMachine LearningMaintenanceManuscriptsMeSH ThesaurusMedical DeviceMedical InformaticsMedical LibrariesMedlinePlusMethodsMinorityMinority-Serving InstitutionModernizationMolecular BiologyMonitorMutationNamesNational Heart, Lung, and Blood InstituteNative-BornOperations ResearchOrganismPacific IslanderPathogen detectionPatientsPersonsPharmaceutical PreparationsPhenotypePlayPoliciesPopulationPopulation GroupPositioning AttributePreparationPrevention MeasuresPrintingProcessProteinsProviderPubMedPublic HealthReadabilityRecording of previous eventsRecordsReduce health disparitiesReportingResearchResearch PersonnelResearch SupportResourcesRoleRouteSARS-CoV-2 genomeSARS-CoV-2 variantSalmonellaSamplingScienceSequence Read ArchiveServicesSourceStandardizationState GovernmentStrategic PlanningSystemSystematized Nomenclature of MedicineTechniquesTechnologyTerminologyTextTherapeuticTimeTrainingTranscriptTranslatingTribesTrustUnderrepresented PopulationsUnited States National Institutes of HealthUnited States National Library of MedicineUpdateVaccinesValidationVariantViralVisualizationanalytical toolarchive dataauthorityautomated analysisbiomedical informaticsbiomedical information systemcloud basedcloud platformcommunity engagementcomparativecomparative genomicscomputerized data processingcoronavirus diseasedata reductiondata standardsdata submissiondigitaldigital medicineelectronic health record systemexhibitionsexperiencefoodborne illnessfoodborne pathogengenome annotationgenome resourcegenome sequencinggenomic datagraphical user interfacehealth datahealth disparityhealth managementimprovedindexinginnovationinteroperabilityjournal articleknowledgebaselecturesonline resourceopen dataoutreachpathogenpetabytepreservationprogramspublic health emergencyrepositoryresearch and developmentresearch studyscientific computingstatisticstoolvirus resourceweb site
项目摘要
In FY 2023, NLM's national biomedical information services expanded and enhanced access to data and information to accelerate biomedical research and public health.
Provided access to biomedical literature
Indexed 1+ million MEDLINE citations with medical subject headings (MeSH). Added 1.6 million citations to PubMed, growing it to 36+ million citations to biomedical literature. Expanded LitCovid to provide enhanced access to 360,000+ SARS-CoV-2 article citations in PubMed.
Added nearly 1 million articles to PubMed Central (PMC) to provide free public access to 9+ million full-text journal articles, 5+ million of which are downloadable in machine-readable forms to support automated analysis through bulk download or at scale in the cloud using machine learning and artificial intelligence. Provided immediate access to 350,000+ coronavirus articles in machine-readable formats through the PMC Public Health Emergency COVID-19 Collection. Expanded the NIH Preprint Pilot to provide access to 10,000+ preprints reporting on NIH-funded research.
Digitized 372,000 pages from print books and journals, making them accessible worldwide through NLMs Digital Collections and PMC. Expanded and maintained other digital collections by adding 5,100+ web resources to a collection that now provides access to 20,000+ resources documenting the COVID-19 pandemic, including content from federal, state, and local governments, aid organizations, and NGOs websites on topics ranging from prevention measures and vaccines.
Filled 56,000 interlibrary loan (ILL) requests. Enabled ILL activities between approximately 1,780 medical libraries to fulfill an estimated 545,000 requests through the NLM DOCLINE ILL request and routing system.
Provided trusted information for biomedical research, public health, and health care management
Registered 37,000 new clinical research studies and added 4,000+ new results summaries to ClinicalTrials.gov, which provides access to 466,000+ studies and 60,000+ results summaries, including 9,000+ COVID-19-related studies. Launched a modernized ClinicalTrials.gov website after a multiyear effort to improve the user experience.
Added 968 million genetic sequences, including 1.5 million SARS-CoV-2 genome sequence records, to the GenBank database of all publicly available DNA sequences. Added 41.7 million records to RefSeq, a database of reference sequences including genomic, transcript, and protein data, which generates comprehensive human genome annotation results. Added 720,000+ annotated human genetic sequence variants to ClinVar, which reports on relationships among human genome variations and human phenotypes.
Provided 25+ million SRA data records (87 petabytes of genetic sequence data) on two commercial cloud providers in three formats, including a post-processed version available through the AWS Open Data Program and a second post-processed version with a greatly reduced data storage footprint, available from commercial AWS and Google cloud platforms to enable the use of machine learning and artificial intelligence. These data included the COVID-19 Genome Sequence Dataset, providing free cloud-based access to SARS-CoV-2 SRA data and controlled access to human genome sequence data derived from research studies.
Supported the SARS-CoV-2 Sequencing for Public Health Emergency Response, Epidemiology, and Surveillance consortium to provide publicly accessible SARS-CoV-2 sequence data in GenBank and SRA. Improved SARS-CoV-2 data submission and validation processes to SARS-CoV-2 virus resources and updated graphic interfaces for viral lineage data retrieval.
Supported processes and infrastructure to monitor and evaluate emerging SARS-CoV-2 variants as part of NIH ACTIV TRACE, and standardized, gathered, and shared variant sequencing data. Supported data processing and analysis methods to track the frequency of SARS-CoV-2 sequence mutations and variants using different genome sequencing technologies and predict their impact on vaccine and biologic early interventions. Provided results of this standardized analysis to support the findability of individual samples and large-scale analysis across the entire dataset.
Continued to develop the NIH Comparative Genomics Resource to facilitate comparative genomics analyses for eukaryotic organisms through an ecosystem of NLM repositories and community-created knowledgebases offering integrated cloud-ready data, tools, and interfaces compatible with community-provided organism resources. Conducted outreach to support a strategy of stakeholder feedback and community engagement. Submitted manuscripts and released tools to improve the quality of genomic data submitted to GenBank for comparative analyses, to assist users to find and download genomic data, and to visualize and identify sequences.
Processed genome sequence data for 416,000+ samples via the Pathogen Detection Pipeline to identify sources of human illnesses such as Salmonella, E. coli, and Listeria. Provided real-time foodborne pathogen surveillance used by the U.S. FDA, resulting in 1,000+ actions to protect consumers from foodborne illness. Provided access to antimicrobial resistance information for nearly 1.2 million pathogens via AMRFinderPlus.
Expanded DailyMed drug labeling information for 145,000+ drugs and added information for 460,000+ medical devices in the AccessGUDID database of more than 4 million medical devices.
Provided trusted health information to an estimated 500 million visitors through MedlinePlus and nearly 200 million patients via electronic health record (EHR) systems via MedlinePlus Connect. Transitioned MedlinePlus Connect to the cloud for faster, more reliable access to critical health information. Provided information to evaluate online health information.
Supported the development and use of health data standards
Coordinated clinical data standards for HHS and provided resources to facilitate interoperability of clinical health data and confirmation of federal EHR interoperability requirements. Updated health data standards resources by expanding the SNOMED International Edition and the U.S. Extension with more than 7,000 and 300 concepts respectively. Added 600+ codes to LOINC and expanded the RxNorm drug terminology by 200+ concepts.
Added 1,700+ federally recognized American Indian and Alaskan Native tribal names and ethnic and ethnolinguistic minority terms designated as "Population Groups" to MeSH. Enhanced the Value Set Authority Center with new features to support maintenance, comparison, tracking of changes, and usage statistics of value sets.
Enhanced the NIH Common Data Element (CDE) Repository to encourage adoption of CDEs in NIH-funded biomedical research. Added 12 CDEs from the NHLBI Collaborating Network of Networks for Evaluating COVID-19 and Therapeutic Strategies program to the NIH-Endorsed CDEs and curated 4 COVID and 5 non-COVID-related CDE submissions in preparation for NIH endorsement, including submission of 30 CDEs from the NIH Science collaborative for Health disparities and Artificial intelligence bias Reduction.
Enhanced public engagement and creation of a diverse workforce
Supported minority-serving institution libraries knowledge and use of the All of Us Researcher Workbench. Provided training on user conduct and access to All of Us data and data engagement techniques via the All of Us data training and engagement for academic libraries program.
Improved public awareness of NLM resources by hosting 7 Michael E. DeBakey Fellows in the History of Medicine to support research using NLM historical collections, an Ada Lovelace Computational Health Lecture highlighting computational innovation efforts to biomedical research, 9 History Talks promoting awareness and use of NLMs historical collections for research, and 38 online exhibitions.
项目成果
期刊论文数量(334)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
RefSeq curation and annotation of antizyme and antizyme inhibitor genes in vertebrates.
- DOI:10.1093/nar/gkv713
- 发表时间:2015-09-03
- 期刊:
- 影响因子:14.9
- 作者:Rajput B;Murphy TD;Pruitt KD
- 通讯作者:Pruitt KD
How to publish a new fungal species, or name, version 3.0.
- DOI:10.1186/s43008-021-00063-1
- 发表时间:2021-05-03
- 期刊:
- 影响因子:5.4
- 作者:Aime MC;Miller AN;Aoki T;Bensch K;Cai L;Crous PW;Hawksworth DL;Hyde KD;Kirk PM;Lücking R;May TW;Malosso E;Redhead SA;Rossman AY;Stadler M;Thines M;Yurkov AM;Zhang N;Schoch CL
- 通讯作者:Schoch CL
RefSeq microbial genomes database: new representation and annotation strategy.
- DOI:10.1093/nar/gkt1274
- 发表时间:2014-01
- 期刊:
- 影响因子:14.9
- 作者:Tatusova T;Ciufo S;Fedorov B;O'Neill K;Tolstoy I
- 通讯作者:Tolstoy I
The NCBI Taxonomy database.
- DOI:10.1093/nar/gkr1178
- 发表时间:2012-01
- 期刊:
- 影响因子:14.9
- 作者:Federhen S
- 通讯作者:Federhen S
RefSeq: an update on prokaryotic genome annotation and curation.
- DOI:10.1093/nar/gkx1068
- 发表时间:2018-01-04
- 期刊:
- 影响因子:14.9
- 作者:Haft DH;DiCuccio M;Badretdin A;Brover V;Chetvernin V;O'Neill K;Li W;Chitsaz F;Derbyshire MK;Gonzales NR;Gwadz M;Lu F;Marchler GH;Song JS;Thanki N;Yamashita RA;Zheng C;Thibaud-Nissen F;Geer LY;Marchler-Bauer A;Pruitt KD
- 通讯作者:Pruitt KD
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Michael Huerta其他文献
Michael Huerta的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
相似国自然基金
基于腔光机械效应的石墨烯光纤加速度计研究
- 批准号:62305039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于自持相干放大的高精度微腔光力加速度计研究
- 批准号:52305621
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
位移、加速度双控式自复位支撑-高层钢框架结构的抗震设计方法及韧性评估研究
- 批准号:52308484
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
高离心加速度行星排滚针轴承多场耦合特性与保持架断裂失效机理研究
- 批准号:52305047
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
基于偏心光纤包层光栅的矢量振动加速度传感技术研究
- 批准号:62305269
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Resources and Workforce Development for Research on NIH/NIAID High Priority Pathogens at the University of Missouri Regional Biocontainment Laboratory
密苏里大学区域生物防护实验室 NIH/NIAID 高优先级病原体研究的资源和劳动力发展
- 批准号:
10793827 - 财政年份:2023
- 资助金额:
$ 35884.77万 - 项目类别:
The impact of vaping aerosol exposure on innate pulmonary defense mechanisms in nonhuman primates
电子烟气溶胶暴露对非人灵长类动物先天肺防御机制的影响
- 批准号:
10594499 - 财政年份:2022
- 资助金额:
$ 35884.77万 - 项目类别:
Impact of high deductible health plans and COVID-19 on alcohol use disorder treatment access, outcomes, and disparities
高免赔额健康计划和 COVID-19 对酒精使用障碍治疗可及性、结果和差异的影响
- 批准号:
10372511 - 财政年份:2022
- 资助金额:
$ 35884.77万 - 项目类别:
Impact of high deductible health plans and COVID-19 on alcohol use disorder treatment access, outcomes, and disparities
高免赔额健康计划和 COVID-19 对酒精使用障碍治疗可及性、结果和差异的影响
- 批准号:
10706546 - 财政年份:2022
- 资助金额:
$ 35884.77万 - 项目类别:
Behavioral and Social Science Research to Optimize SARS-CoV-2 Protective Vaccine Uptake in Racial Minority Communities with High Rates of COVID-19
通过行为和社会科学研究优化 COVID-19 高发病率的少数族裔社区对 SARS-CoV-2 保护性疫苗的接种
- 批准号:
10628038 - 财政年份:2021
- 资助金额:
$ 35884.77万 - 项目类别: